IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Displaying 421 - 440 of 1133 stories.
August 28, 2012
MANUFACTURERS REQUIRE TO SELF-IDENTIFY UNDER GDUFA The U.S. FDA is establishing a new system for the electronic self-identification of generic industry facilities, sites, and...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-August-28_45850.html
August 21, 2012
CAMBREX SIGNS API MANUFACTURING DEAL, TO EXPAND PRODUCTION CAPACITY Cambrex (East Rutherford, NJ) says it has entered into an agreement to supply an active pharmaceutical ingredient...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-August-21_45753.html
August 17, 2012
The active pharmaceutical ingredient (API) business segment of Perrigo (Allegan, MI) reported a 4.3% rise in sales in its fiscal fourth quarter, ended June 30, 2012, compared with the...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Perrigos-API-Business-Reports-Rise-in-Sales-Operating-Profits_45709.html
August 15, 2012
Cambrex (East Rutherford, NJ) says it has entered into an agreement to supply an active pharmaceutical ingredient (API) for a customer's Phase 3 program during 2013–2014. The...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Cambrex-Signs-API-Manufacturing-Deal-to-Expand-Production-Capacity_45628.html
August 14, 2012
CAMBREX REPORTS HUGE RISE IN PROFITS Cambrex (East Rutherford, NJ) reported a more than doubling in net profits for the second quarter, ended June 30, 2012, compared with the year-ago...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-August-14_45603.html
August 10, 2012
Ampac Fine Chemicals (AFC; Rancho Cordova, CA), a subsidiary of American Pacific (Las Vegas), recorded an operating profit of about $5.2 million in its fiscal third quarter, ended June...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Ampac-Fine-Chemicals-Reports-Operating-Profits_45546.html
August 7, 2012
The answer to the question is: It depends. This are not the answer one would expect from anyone who is a proponent of continuous processing. Indeed, “it depends” needs...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Is-Continuous-Processing-in-Pharmas-Future_45489.html
August 2, 2012
Cambrex (East Rutherford, NJ) reported a more than doubling in net profits for the second quarter ended June 30, 2012, compared with the year-ago quarter, to $9.92 million. Net sales...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Cambrex-Reports-Huge-Rise-in-Profits_45354.html
July 31, 2012
LONZA REPORTS FALL IN FIRST-HALF PROFITS Lonza recorded a 3.1% fall in first-half profits compared with the year-ago period, to SF94 million ($94.5 million). First-half sales...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-July-31_45286.html
July 30, 2012
Pharmaceutical company Dr. Reddy’s Laboratories (Hyderabad, India) says that the U.S. FDA has lifted the import alert on Industrias Químicas Falcon de México...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/U-S-FDA-Lifts-Import-Alert-on-Dr-Reddys-API-Facility-in-Mexico_45246.html
July 25, 2012
Lonza recorded a 3.1% fall in first-half profits compared with the year-ago period, to SF94 million ($94.5 million). First-half sales increased, however, by 64.6%, to SF1.96 billion...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Lonza-Reports-Fall-in-First-Half-Profits_45170.html
July 24, 2012
NOVASEP EXPANDS HPAPI MANUFACTURING FACILITY IN FRANCE Novasep (Pompey, France) says it will expand its highly potent active pharmaceutical ingredients (HPAPIs) manufacturing...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-July-24_45140.html
July 19, 2012
Novasep (Pompey, France) says it will expand its highly potent active pharmaceutical ingredients (HPAPI) manufacturing capabilities at the company's Le Mans, France facility. The...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Novasep-Expands-Its-HPAPI-Manufacturing-Facility-in-France_45009.html
July 17, 2012
DSM’s pharmaceutical division has signed its first contract manufacturing agreement in South America, the company says. Under the agreement, DSM with work with Recepta Bioopharma...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/DSM-Signs-Contract-Manufacturing-Deal-in-Brazil_44939.html
July 17, 2012
Foster Wheeler says that one of its global engineering and construction group subsidiaries has been awarded an engineering, procurement, and construction management (EPCM) services...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Foster-Wheeler-Receives-Contract-for-API-Plant-Conversion-in-the-U-K-_44933.html
July 16, 2012
President Obama has signed into law a measure that will revise FDA’s ability to oversee certain provisions related to pharmaceutical ingredients and includes a generic drug...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/U-S-Enacts-Bill-Creating-Generic-Drug-User-Fee-Program_44918.html
July 10, 2012
Mylan (Canonsburg, PA) says it applauds President Barack Obama’s signing of the Food and Drug Administration Safety and Innovation Act, legislation that will significantly...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Mylan-Welcomes-FDA-Safety-and-Innovation-Act_44793.html
July 10, 2012
OBAMA SIGNS OFF ON FDA GENERIC DRUG USER FEE ACT - Lindsay Frost President Obama has signed into law a measure that will revise FDA’s ability to oversee certain provisions...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-July-10_44794.html
July 10, 2012
Lonza says it has launched the new GS Xceed gene expression system—the latest generation of Lonza’s GS System, which has been used to create more than 100 cell lines and 13...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Lonza-Launches-New-GS-Gene-Expression-System_44786.html
July 9, 2012
President Obama has signed into law a measure that will revise FDA’s ability to oversee certain provisions related to pharmaceutical ingredients and includes a generic drug...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Obama-Signs-Off-on-FDA-Generic-Drug-User-Fee-Act_44782.html
Pages: « Previous  13 14 15 16 17 18 19 20 21 [22] 23 24 25 26 27 28 29 30 31 Next »










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa